Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Boston Scientific Corp shares valued at $5,799,630 were sold by Fitzgerald Joseph Michael on Jun 04 ’25. At $102.88 per share, Fitzgerald Joseph Michael sold 56,372 shares. The insider’s holdings dropped to 178,342 shares worth approximately $18.6 million following the completion of this transaction.
Also, JOSEPH M FITZGERALD purchased 56,372 shares, netting a total of over 5,799,625 in proceeds.
Before that, Mahoney Michael F had sold 164,443 shares from its account. In a trade valued at $17,051,136, the Chairman, President & CEO traded Boston Scientific Corp shares for $103.69 each. Upon closing the transaction, the insider’s holdings decreased to 164,443 shares, worth approximately $154.02 million.
As published in their initiating research note from Leerink Partners on June 16, 2025, Boston Scientific Corp [BSX] has been an Outperform and the price target has been revised to $118. Analysts at Needham upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid April. As of January 10, 2025, Deutsche Bank has increased its “Hold” rating to a “Buy” for BSX. Earlier on October 18, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for BSX stock which previously was a “a Buy”.
Analyzing BSX Stock Performance
On last trading session,, Boston Scientific Corp [NYSE: BSX] rose 0.16% to $104.29. The stock’s lowest price that day was $104.011, but it reached a high of $105.09 in the same session. During the last five days, there has been a surge of approximately 2.52%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 34.20%. Shares of the company reached a 52-week high of $107.17 on 02/05/25 and a 52-week low of $85.98 on 04/07/25.
Support And Resistance Levels for Boston Scientific Corp (BSX)
According to the 24-hour chart, there is a support level at 103.84, which, if violated, would cause prices to drop to 103.38. In the upper region, resistance lies at 104.92. The next price resistance is at 105.54. RSI (Relative Strength Index) is 59.38 on the 14-day chart, showing neutral technical sentiment.
Is Boston Scientific Corp subject to short interest?
Stocks of Boston Scientific Corp saw a sharp rise in short interest on 2025-05-30 jumping by 1.31 million shares to 17.02 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 15.71 million shares. A jump of 7.69% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.53 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.53.
Which companies own the most shares of Boston Scientific Corp (BSX)?
In terms of Boston Scientific Corp share price expectations, FactSet research, analysts set an average price target of 117.5 in the next 12 months, up nearly 12.85% from the previous closing price of $104.12. Analysts anticipate Boston Scientific Corp stock to reach 130 by 2025, with the lowest price target being 100. In spite of this, 15 analysts ranked Boston Scientific Corp stock as Buy at the end of 2025. On May 30, 2024, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $90.
